NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » pressreleases » Tosla’s new generation sugar technology EU funding was approved: SLADCORE™, sugar re-invented

Sugar reduction versus clean label

Press
Release

Tosla’s new generation sugar technology EU funding was approved: SLADCORE™, sugar re-invented

Tosla’s submission was approved in the latest Phase 1 round in the Horizon 2020 SME Instruments programme.

The SLADCORE™ project aims to reinvent sugar through technology. The final product will be a next-generation sucrose with more than 40 percent increased sweetness and breakthrough plug-n-play sugar manufacturing technology. Thanks to this EU contribution, the company now has the necessary funding to conclude lab trials and prepare the feasibility study for the next phase application under the Horizon 2020 SME Instruments financing.

"Over the last two years Tosla has made several laboratory experiments aiming at developing a technology of natural modification of the sucrose structure. SLADCORE™ project is both a transformational technology process and the novelty food it produces," says Primoz Artac, CEO of Tosla.

Through structural modification of table sugar, the SLADCORE™ team has invented a plug-n-play disruptive industrial technology to improve sucrose (40% increased sweetness).

Contact Sugar reduction versus clean label

Sugar reduction versus clean label